• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.

作者信息

Folprecht G, Köhne C H, Lutz M P

机构信息

University Hospital Carl Gustav Carus, Dresden, Germany.

出版信息

Cancer Treat Res. 2007;134:425-40. doi: 10.1007/978-0-387-48993-3_28.

DOI:10.1007/978-0-387-48993-3_28
PMID:17633071
Abstract
摘要

相似文献

1
Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.结直肠癌腹膜转移患者的全身化疗
Cancer Treat Res. 2007;134:425-40. doi: 10.1007/978-0-387-48993-3_28.
2
Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.根据回顾性腹膜表面疾病严重程度评分（PSDSS）对结直肠来源腹膜癌患者进行最佳支持治疗和全身化疗分层治疗的评估。
BMC Cancer. 2010 Dec 22;10:689. doi: 10.1186/1471-2407-10-689.
3
HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin.奥沙利铂腹腔热灌注化疗治疗结直肠癌源性腹膜癌病
Cancer Treat Res. 2007;134:303-18. doi: 10.1007/978-0-387-48993-3_19.
4
The European contribution to "Sugarbaker's protocol" for the treatment of colorectal peritoneal carcinomatosis.欧洲对治疗结直肠腹膜转移癌的“苏格贝克方案”的贡献。
Rev Esp Enferm Dig. 2009 Feb;101(2):97-102, 103-6. doi: 10.4321/s1130-01082009000200003.
5
Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.伊立替康或奥沙利铂联合氟尿嘧啶和亚叶酸钙作为晚期结直肠癌一线治疗的疗效比较：一项荟萃分析。
Chin Med J (Engl). 2010 Nov;123(22):3314-8.
6
Second line therapies move to the forefront in colorectal cancer.二线治疗在结直肠癌治疗中占据前沿地位。
J Natl Cancer Inst. 1999 Jun 16;91(12):998-1000. doi: 10.1093/jnci/91.12.998.
7
Treatment results of peritonectomy combined with perioperative chemotherapy for colorectal cancer-patients with peritoneal carcinomatosis.结直肠癌伴腹膜转移患者行腹膜切除术联合围手术期化疗的治疗结果
Gan To Kagaku Ryoho. 2011 Nov;38(12):1987-91.
8
Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.完整细胞减灭术联合奥沙利铂腹腔热灌注化疗治疗结直肠源性腹膜癌病
J Clin Oncol. 2009 Feb 10;27(5):681-5. doi: 10.1200/JCO.2008.19.7160. Epub 2008 Dec 22.
9
Second-line therapy in colorectal cancer.结直肠癌的二线治疗
Oncology (Williston Park). 2000 Dec;14(12 Suppl 11):21-6.
10
Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin.34 例阑尾来源的黏液性腹膜癌患者行新辅助 FOLFOX 化疗。
J Surg Oncol. 2010 Nov 1;102(6):576-81. doi: 10.1002/jso.21679.

引用本文的文献

1
Prognostic significance of peritoneal metastasis from colorectal cancer treated with first-line triplet chemotherapy.一线三联化疗治疗的结直肠癌腹膜转移的预后意义
World J Clin Cases. 2022 Mar 16;10(8):2429-2438. doi: 10.12998/wjcc.v10.i8.2429.
2
Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases.腹腔内热灌注化疗治疗结直肠腹膜转移。
Ann Surg Oncol. 2021 Sep;28(9):5275-5286. doi: 10.1245/s10434-020-09508-0. Epub 2021 Jan 20.
3
Prophylactic HIPEC in pT4 Colon Tumors: Proactive Approach or Overtreatment?
预防性 HIPEC 在 pT4 结直肠肿瘤中的应用：积极治疗还是过度治疗？
Ann Surg Oncol. 2020 Apr;27(4):1094-1100. doi: 10.1245/s10434-019-07970-z. Epub 2019 Oct 29.
4
Therapeutic efficacy of systemic therapy for colorectal peritoneal carcinomatosis: Surgeon's perspective.结直肠癌腹膜转移的全身治疗疗效：外科医生的观点。
Pleura Peritoneum. 2018 Mar 16;3(1):20180102. doi: 10.1515/pp-2018-0102. eCollection 2018 Mar 1.
5
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastrointestinal cancers: fad or standard of care?胃肠道癌症的细胞减灭术和腹腔内热灌注化疗：时尚还是治疗标准？
Singapore Med J. 2018 Mar;59(3):116-120. doi: 10.11622/smedj.2018025.
6
Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin.结直肠癌异时性腹膜转移癌患者的全身治疗。
Sci Rep. 2015 Dec 21;5:18632. doi: 10.1038/srep18632.
7
Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only.结直肠腹膜转移的细胞减灭术：完全细胞减灭术后和单纯全身化疗的结果。
PLoS One. 2015 Mar 31;10(3):e0122816. doi: 10.1371/journal.pone.0122816. eCollection 2015.
8
Oxaliplatin and molecular-targeted drug therapies improved the overall survival in colorectal cancer patients with synchronous peritoneal carcinomatosis undergoing incomplete cytoreductive surgery.奥沙利铂和分子靶向药物疗法改善了接受不完全细胞减灭术的同时性腹膜癌转移结直肠癌患者的总生存期。
Surg Today. 2015 Aug;45(8):986-92. doi: 10.1007/s00595-014-1017-y. Epub 2014 Aug 26.
9
Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options.结直肠来源的腹膜癌病：发生率、预后和治疗选择。
World J Gastroenterol. 2012 Oct 21;18(39):5489-94. doi: 10.3748/wjg.v18.i39.5489.
10
Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer.结直肠癌腹膜转移的多模态治疗方法。
Dtsch Arztebl Int. 2011 Nov;108(47):802-8. doi: 10.3238/arztebl.2011.0802. Epub 2011 Nov 25.